BRANMOOR
THURSDAY · 14 MAY 2026

FDA Device Recall Z-1614-2024

ROUTE 92 MEDICAL INC · San Mateo, CA

Class I — life-threatening Ongoing

Highest impact — Class I device recall — FDA determination that use of, or exposure to, the device will cause serious adverse health consequences or death.

Device

Route 92 Medical 070 Reperfusion System, REF 1003, Rxonly, SterileEO. Used for introduction of interventional devices into the neurovasculature and aspiration of thrombus in ischemic stroke patients.

Lot / serial / GTIN: UDI: 00853799007169/ Lot # 23112702 and 23112901

Quantity: 19 units

Reason for recall

Their is the potential for distal tip separation at the proximal marker band of the delivery catheters

Recall record

Recall number
Z-1614-2024
Classification
Class I
Status
Ongoing
Voluntary or mandated
Voluntary: Firm initiated
Firm notification
Letter
Distribution
US: AL AZ CA DE FL GA IA IL IN KY LA MA MD MI MN MO NC ND NJ NY OH OR PA RI SD TN TX UT VA WV OUS: New Zealand
Recall initiated
2024-03-08
Classified by FDA Center
2024-04-24
FDA published
2024-05-01
Recalling firm
ROUTE 92 MEDICAL INC
Firm location
San Mateo, CA

Operational response

A Class I device recall indicates a strong likelihood of serious adverse health consequence or death from continued use. Identify affected units by serial number, lot, or GTIN against your inventory and against implanted-device patient registry. Pull affected inventory from active use immediately. For implanted devices, follow the recalling firm’s patient-notification protocol; in most cases this requires informing affected patients and their treating physicians directly.

For the official FDA enforcement record, see FDA's Recall Search.

‹ All device recalls